UFP Technologies (NASDAQ:UFPT) versus Apyx Medical (NASDAQ:APYX) Head-To-Head Analysis

UFP Technologies (NASDAQ:UFPT) and Apyx Medical (NASDAQ:APYX) are both small-cap industrial products companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, analyst recommendations, risk, valuation, institutional ownership and earnings.

Insider & Institutional Ownership

87.3% of UFP Technologies shares are owned by institutional investors. Comparatively, 55.3% of Apyx Medical shares are owned by institutional investors. 6.2% of UFP Technologies shares are owned by insiders. Comparatively, 13.1% of Apyx Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Volatility & Risk

UFP Technologies has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500. Comparatively, Apyx Medical has a beta of 1.25, suggesting that its share price is 25% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations for UFP Technologies and Apyx Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UFP Technologies	0	1	1	0	2.50
Apyx Medical	0	0	2	0	3.00

UFP Technologies currently has a consensus price target of $238.50, suggesting a potential downside of 6.02%. Apyx Medical has a consensus price target of $4.75, suggesting a potential upside of 249.26%. Given Apyx Medical’s stronger consensus rating and higher possible upside, analysts clearly believe Apyx Medical is more favorable than UFP Technologies.

Valuation & Earnings

This table compares UFP Technologies and Apyx Medical’s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UFP Technologies	$400.07 million	4.87	$44.92 million	$6.22	40.80
Apyx Medical	$52.35 million	0.90	-$18.71 million	($0.66)	-2.06

UFP Technologies has higher revenue and earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares UFP Technologies and Apyx Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
UFP Technologies	11.75%	17.40%	12.04%
Apyx Medical	-45.20%	-76.16%	-32.98%

Summary

UFP Technologies beats Apyx Medical on 9 of the 14 factors compared between the two stocks.

About UFP Technologies

UFP Technologies, Inc. designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners. It also provides molded composites for commercial aviation and military gear for use in backpack components, knee and elbow pads, eyewear, and helmets; and reusable cases and custom for applications in military ballistics panels, virtual training systems, drones, communications equipment, and rugged portable computers. In addition, the company provides engineered products and components to customers in the automotive, aerospace and defense, and industrial markets for applications in military uniform and gear components, automotive interior trim, air filtration, and protective cases and inserts. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.